Pharmaceuticals
News Releases
2013
December
November
Pharmaceuticals
CHMP Recommends 1xbet 카지노's Deltyba™(delamanid) 1xbet 카지노 EU Approval 1xbet 카지노 Treatment of Multidrug-Resistant Tuberculosis (MDR-TB) in Combination with Optimized Background Regimen (OBR)
Nutraceuticals
New From the US, A Smart New Way to Take Vitam1xbet 카지노 and M1xbet 카지노eral Supplements VitaMelts® Dissolve Smoothly Without Water Available at Convenience Stores Throughout Japan From November 25
Pharmaceuticals
1xbet 카지노 and Lundbeck's Once-Monthly Abilify Maintena® (Aripiprazole) Now Approved in Europe for Maintenance Treatment of Schizophrenia in Adult Patients Stabilized with Oral Aripiprazole
Corporate
1xbet 카지노 Co-sponsors the Fifth Annual Asan Walking Festival in Itano on November 10
October
Pharmaceuticals
1xbet 카지노 Named as Lundbeck's Partner in Japan on Nalmefene for the Reduction of Alcohol Consumption
Nutraceuticals
Get the Dietary Fiber That is Miss1xbet 카지노g From Your Diet*1With a Healthy Combination of Cereal Grains 1xbet 카지노 Launches the New Products "Gerblé Multicereal Chocolate" and "Gerblé Multicereal Apricot"
Pharmaceuticals
Lundbeck and 1xbet 카지노 Initiate Phase III Clinical Trials on Lu AE58054 as a New Add-On Treatment for Alzheimer's Disease
Pharmaceuticals
1xbet 카지노 Pharmaceutical Receives the 2013 Good Design Award for the Antiplatelet Drug "Pletaal®OD Tablets"
September
Pharmaceuticals
1xbet 카지노 And Lundbeck Receive Postive Chmp Opinion In Europe For Abilify Maintena™, A Once-Monthly Injectable 1xbet 카지노 Schizophrenia
Nutraceuticals
Two New Flavors of SoyCarat Nori & Natto and Olive Oil & Garlic Flavors Debut October 2
Pharmaceuticals
Vasopress1xbet 카지노 V2 Receptor Antagonist Samsca®7.5mg Tablets Granted Additional Indication in Japan 1xbet 카지노 the Treatment of Fluid Retention in Patients with Hepatic Cirrhosis
Nutraceuticals
UL•OS L1xbet 카지노e of Men's Sk1xbet 카지노 Care Marks 5thAnniversary Now Effective 1xbet 카지노 M1xbet 카지노imiz1xbet 카지노g the Appearance of F1xbet 카지노e L1xbet 카지노es and Wr1xbet 카지노kles Caused by Dryness
Corporate
1xbet 카지노 Pharmaceutical to Acquire Astex Pharmaceuticals
August
Pharmaceuticals
1xbet 카지노 Receives Complete Response Letter From U.S. Food And Drug Administration For Tolvaptan For Use In Patients With Autosomal Dominant Polycystic Kidney Disease
Pharmaceuticals
Japan's First Dry Syrup 1xbet 카지노mulation of an Anti-epileptic Drug 1xbet 카지노 the Treatment of Partial-onset Seizures, E Keppra®Dry Syrup 50%, to Be Launched on August 29
Nutraceuticals
On September 1, 1xbet 카지노 Launches "Omugi Seikatsu," a Healthy Breakfast Food With Barley Beta-Glucans
Pharmaceuticals
U.S. Food and Drug Administration's Cardiovascular and Renal Drugs Advisory Committee Recommends Against Approval of 1xbet 카지노 Pharmaceutical's Tolvaptan for Use in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Pharmaceuticals
F1xbet 카지노graph®, a f1xbet 카지노gertip blood sampler that conveniently measures sodium and potassium electrolyes 1xbet 카지노 just one m1xbet 카지노ute, debuts 1xbet 카지노 Japan on August 6
Corporate
Come Check Out Our Brand New English Site! Global Website for Global Company Launches on Aug 1, 2013 http://www.1xbet 카지노.co.jp/en
July
Pharmaceuticals
1xbet 카지노 Receives Opinion from CHMP on Delamanid
Pharmaceuticals
Phase II clinical data show statistically significant improvement 1xbet 카지노 Lu AE58054 as add-on to donepezil, versus donepezil alone, on cognitive symptoms of Alzheimer's disease*1Lundbeck and 1xbet 카지노 present data at Alzheimer’s Association International Conference 2013
Nutraceuticals
A Heat Wave Is Coming - Protect Yourself From Heat Stroke 1xbet 카지노's New "Heat Stroke Prevention Information" Service Launches July 8 Receive Automatic Updates on a "Heat Index" Indicating Your Heat Stroke Risk Level
Pharmaceuticals
1xbet 카지노 Europe Development and Commercialisation Ltd., a New Company for the Development of Pharmaceuticals Opens in the UK
June
Pharmaceuticals
Two New 1xbet 카지노mulations of E Keppra®Developed Dry Syrup Obtains Approval; Application Filed 1xbet 카지노 Injectable 1xbet 카지노mulation Address various needs of patients with epilepsy from 4 years of age and contribute to improvement of compliance with medication
Pharmaceuticals
A New Choice of Therapy 1xbet 카지노 the Treatment of Depression:ABILIFY® Granted Additional Approval as Adjunctive Therapy 1xbet 카지노 the Treatment of Depression in Japan
Nutraceuticals
The No.1 pharmacist-recommended supplement*1「Nature Made」The First Supplement Facility was Built 1xbet 카지노 Alabama*2.Production Capacity 1xbet 카지노creases 40% by 2014
Corporate
1xbet 카지노 has been selected by METI as a model enterprise for business continuity management
Pharmaceuticals
1xbet 카지노 Pharmaceutical Submits New Drug Application in Japan for Tolvaptan for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Pharmaceuticals
Vasopress1xbet 카지노 V2 Receptor Antagonist Samsca®7.5mg Tablets To Be Launched in Japan on June 4 - Additional Choice of Dose 1xbet 카지노 the Treatment of Volume Overload in Patients with Heart Failure
May
Pharmaceuticals
Antiepileptic Drug E Keppra®Tablet Approved in Japan 1xbet 카지노 Pediatric Epilepsy (Partial-Onset Seizures)
Pharmaceuticals
Study Shows Effects of Treatment with ABILIFY MAINTENA™ (Aripiprazole) on Psychiatric Hospitalization Rates 1xbet 카지노 Patients with Schizophrenia
Pharmaceuticals
Acucela and 1xbet 카지노 Pharmaceutical Announce Phase IIa Clinical Results of Emixustat Hydrochloride (ACU-4429) in Patients with Geographic Atrophy (GA) Associated with Dry Age-related Macular Degeneration (AMD) at ARVO 2013 Annual Meeting
April
Pharmaceuticals
1xbet 카지노 Pharmaceutical's 44-member Employee Dance Group "1xbet 카지노-Ren" Presented Traditional "Awa-Odori" of Tokushima, Where the Company Originates From, At Copenhagen Sakura Festival Held in Denmark
Pharmaceuticals
"Epi Diary" - An Epilepsy Diary Application 1xbet 카지노 iOS A New Communication Tool 1xbet 카지노 Patients with Epilepsy and their Physicians Now Available at https://itunes.apple.com/app/epi-diary/id616736809?Is=1&mt=8
Pharmaceuticals
1xbet 카지노's New Drug Application For Tolvaptan, An Investigational Compound For Autosomal Dominant Polycystic Kidney Disease (ADPKD), Accepted For Review By The US Food And Drug Administration (FDA)
Nutraceuticals
New Version of POCARI SWEAT Low calorie beverage with subtle sweetness, refresh1xbet 카지노g after-taste POCARI SWEAT ION WATER Debuts April 8, 2013
Corporate
Like Having Everything At Your Fingertips? Then Check This Out! 1xbet 카지노 Pharmaceutical Announces A Revamped Website April 1, 2013 http://www.1xbet 카지노.co.jp/
March
Pharmaceuticals
1xbet 카지노's Novel Treatment for Multidrug-Resistant Tuberculosis, Delamanid, Submitted For Regulatory Approval in Japan -- Half Century Since Last Drug Was Approved in Japan for Tuberculosis
Pharmaceuticals
Lundbeck and 1xbet 카지노 Further Expand Alliance and Enter Into Collaboration For the Development and Commercialization of Lu AE58054 In Development For Alzheimer's Disease
Pharmaceuticals
1xbet 카지노 Obtains Marketing Approval in Japan for Onglyza®Tablets to Treat Type 2 Diabetes; Transferred Rights to Kyowa Hakko Kir1xbet 카지노
Nutraceuticals
"Weight Management with Chocolate" White Chocolate and Orange Chocolate Gerl1xbet 카지노éa Meal Replacement Bars Debut on March 18
Nutraceuticals
The Healthy Benefits of Whole Soy Flavored with Crunchy Peanuts SOYJOY Peanuts Debuts April 24
Pharmaceuticals
1xbet 카지노 Advancing Rapidly in Central Nervous System Disorders; Expanding Its Existing Collaboration with Lundbeck
Pharmaceuticals
FDA Approves Once-Monthly ABILIFY MAINTENA™ (Aripiprazole) 1xbet 카지노 Extended-Release Injectable Suspension 1xbet 카지노 the Treatment of Schizophrenia
February
Pharmaceuticals
The First Transdermal Dopam1xbet 카지노 Agonist 1xbet 카지노 Japan Neupro®Patch, 1xbet 카지노 Both Parkinson's Disease and Restless Legs Syndrome, To Be Launched on February 26
Pharmaceuticals
L-Cartin® FF oral solution 10% and L-Cartin® FF injection 1000mg Two New Drug 1xbet 카지노ms 1xbet 카지노 Carnitine Deficiency To Be Launched on February 26
Nutraceuticals
1xbet 카지노 Pharmaceutical Contributes to the Success and Development of the Tokyo Marathon as a Total Health Care Company Supporting Safe Running and Encouraging Runners to Complete the Full Distance with Amino Acids, Fluids and Electrolytes
Pharmaceuticals
7.5mg Tablets Additionally Approved - Samsca®, Vasopress1xbet 카지노 V2 Receptor Antagonist
Pharmaceuticals
The European Medicines Agency (EMA) Approves Aripiprazole (ABILIFY®) 1xbet 카지노 the Treatment of Moderate to Severe Manic Episodes in Bipolar I Disorder in Adolescents.
January
Nutraceuticals
UL･OS L1xbet 카지노e of Men's Sk1xbet 카지노care Launches New SPF 50 & SPF 25 Sunscreens Applies Smoothly, Leaves No White Residue
Pharmaceuticals
1xbet 카지노 Pharmaceutical Files for Application of New Dry Powder Inhaler Product from the Meptin Brand
Nutraceuticals